Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 7,513 articles

Articles by Daniel Marsh

Social Security COLA 2027 Forecast: 3.8% Increase, $63B Payout, Medicare Premiums Rise
Economy

Social Security COLA 2027 Forecast: 3.8% Increase, $63B Payout, Medicare Premiums Rise

The Senior Citizens League forecasts a 3.8% Social Security COLA for 2027, adding $63B in annual payouts, but Medicare Part B premium hikes will offset some gains for retirees.

SPY
Stock Futures Climb as Oil Slumps Ahead of Key Jobs Report and AI Earnings
Markets

Stock Futures Climb as Oil Slumps Ahead of Key Jobs Report and AI Earnings

US stock futures advanced Monday as oil prices plunged over 6% on diplomatic hopes, while investors braced for July jobs data and a busy week of major tech earnings.

AMZN MSFT AAPL PLTR AMD LLY SNDK
Markets Steady as Oil Plunges 6% and AI Earnings Loom
Markets

Markets Steady as Oil Plunges 6% and AI Earnings Loom

U.S. futures gain as oil plunges 6%, Derwent London hits a new high, and Flutter completes its NYSE transition. Investors await jobs data and AI earnings.

FLUT MMM AMZN USO
Nu Holdings Faces Valuation Test Ahead of Mexico Bank Launch
Analysis

Nu Holdings Faces Valuation Test Ahead of Mexico Bank Launch

Nu Holdings (NU) rose 1.7% last week, but its valuation remains stretched at 22.1x trailing earnings. Mexico bank launch and rate decision loom.

NU INTR
SK hynix ADR Premium Narrows to 21% After Seoul Shares Surge
Markets

SK hynix ADR Premium Narrows to 21% After Seoul Shares Surge

SK hynix shares surged 30% in Seoul, narrowing the ADR premium to ~21%. Q2 results missed estimates on HBM4 delays, but demand stays robust.

MU AMD
Bristol Myers Squibb at Crossroads as AstraZeneca Merger Talks Surface
Markets

Bristol Myers Squibb at Crossroads as AstraZeneca Merger Talks Surface

Bristol Myers Squibb shares rose 5.2% last week after strong Q2 earnings, but a reported $400B merger approach from AstraZeneca puts the stock in focus Monday.

BMY AZN PFE
Alphabet's $119B AI Bet Puts Rebound at Risk
Analysis

Alphabet's $119B AI Bet Puts Rebound at Risk

Alphabet's recovery faces a crucial test as it plans $119B in AI spending, potentially straining cash flow despite strong cloud growth. Markets watch AMD earnings and jobs data.

GOOGL AMD MSFT AMZN
AZN-BMY Merger Talks: A $455B Pharma Mega-Deal in the Making?
Analysis

AZN-BMY Merger Talks: A $455B Pharma Mega-Deal in the Making?

AstraZeneca and Bristol Myers Squibb are reportedly in merger talks, which could create a $455 billion pharmaceutical giant. Reuters has not confirmed the report.

AZN BMY ABBV MRK LLY JNJ NVS
GM Stock Surges 7.5% on Strong Sales, But Valuation Gap with Ford Narrows Slowly
Markets

GM Stock Surges 7.5% on Strong Sales, But Valuation Gap with Ford Narrows Slowly

GM shares gained 7.5% last week, yet its valuation multiple still trails Ford's. Strong Q2 margins and raised guidance support the stock, but the gap remains.

GM F STLA
Raising Cane's August Expansion Plan Signals Shift in Chicken Brand Growth
Analysis

Raising Cane's August Expansion Plan Signals Shift in Chicken Brand Growth

Raising Cane's will open seven new restaurants in August, including two in new markets, as the chicken chain aims for 100 openings in 2026.

WING YUM QSR
Credo Stock Rebounds but Valuation Concerns Persist
Analysis

Credo Stock Rebounds but Valuation Concerns Persist

Credo Technology shares rebounded 16.6% over two sessions but remain 31.6% below record highs, with valuation at 20.5 times sales prompting caution.

CRDO ALAB MRVL AMD
Student Loan Settlement Fuels Private Lender Optimism
Analysis

Student Loan Settlement Fuels Private Lender Optimism

A federal appeals court expanded student loan relief to over 450,000 borrowers, totaling $23B. Private lenders like SLM, SoFi, and Nelnet may benefit as federal graduate lending ends.

SLM SOFI NNI